Navigation Links
Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
Date:12/10/2009

rm other promoted medicines in an antidepressant and pain market that has seen increasing use of generics and relatively modest growth overall. Cymbalta's international growth has been driven by recent approvals for depression in new markets, complemented by growth from other indications in existing markets. Plans are in place to enter the Japanese market in the near future. Cymbalta is under regulatory review for chronic pain in the U.S., and was recently approved by both Mexico and Brazil for this indication. The company expects additional international regulatory submissions in 2010.

Zyprexa continues to be the company's best-selling medicine. More than half of Zyprexa's sales now come from international markets, although U.S. Zyprexa sales still grew 4 percent in the first nine months of 2009. Zyprexa has obtained approvals for additional indications in the U.S. in 2009, and awaits final action from the FDA on Zyprexa Relprevv®, or long-acting injection. Lilly re-launched Zyprexa in Germany in early 2009 after the successful appeal of a patent decision. Share of market is stable in other EU countries and continues to grow in Japan. In other Asian nations, including China, the company expects current strong sales trend to continue.

Cialis (tadalafil) continues to demonstrate solid growth. Over the first three quarters of 2009, Cialis has grown 4 percent to $1.1 billion in sales worldwide, while the global ED market has grown only 1 percent. In the U.S., Cialis has grown 17 percent and has achieved market leadership with urologists. Internationally, Cialis is now available in more than 100 countries and is the market leader in more than 20, including 6 of the top 8 international markets. Tadalafil also has been studied for pulmonary arterial hypertension (PAH) and benign prostatic hyperplasia (BPH). The PAH indication was approved by the FDA in May and launched in August by Lilly's partner, United Therapeutics, under the brand name Ad
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  ConvaTec, a privately-held medical ... Clerkin has been appointed chief financial officer of ... Clerkin was previously executive vice president and chief financial ... -based biotechnology company.  Mr. Clerkin was part of a ... Elan, culminating in its sale to Perrigo, a pharmaceutical ...
(Date:7/22/2014)... 2014 The steady decline of pharmaceutical ... previously rep-friendly specialties, according to the spring 2014 ... firm ZS Associates.      AccessMonitor™ aggregates ... sales teams. The report examines how often approximately ... pharmaceutical sales reps who visit their offices. ...
(Date:7/22/2014)... 2014 WuXi PharmaTech (Cayman) Inc. (NYSE: ... outsourcing company with operations in China ... that it will release financial results for the second quarter ... Wednesday, August 13, 2014 (which will be Thursday morning, August ... on the investor relations section of the Company,s website at ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
... 10, 2011 USANA Health Sciences, Inc. (NYSE: ... nutritional gaps are common in the average American diet and ... those gaps.  However, USANA scientists and advising physicians caution that ... Dietary Guidelines for Americans, 2010 and ...
... MATEO, Calif., Feb. 10, 2011 AlphaDetail, a leader ... biotech industries, reported a 30% increase in revenue in ... time in the company,s history. "Our clients ... provides the marketing research solutions that get at the ...
Cached Medicine Technology:USDA Recognizes Benefit of Supplements in New Dietary Guidelines But Doesn't Go Far Enough 2AlphaDetail Revenue Soars 30% in 2010 2
(Date:7/22/2014)... July 22, 2014 Alan Tonelson of ... young child. While most kids outgrow the inhibiting speech ... He is among the three million people in the ... mild to severe. Throughout his youth, he participated in ... sessions and visits with private speech-and-language pathologists. None helped ...
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person Should Know ... young people can read. , But be careful! What’s in this ... people have been living with all their lives. And If the ... sex to death, this self-help book deals directly with social reality ... it like it is. , Tune in to “The Big Secrets” ...
(Date:7/22/2014)... 2014 One woman who looked at diet ... 20 pounds. Unfortunately, the weight loss came at a price ... of her time using the pill, and says her personality ... and insomnia as a result of the caffeine content of ... the age of 37 because of a diet pill she ...
(Date:7/22/2014)... Industry-leading health business information publisher Atlantic Information Services ... Pharmacy Trends and Strategies: 2014 , the latest edition ... of the current state of the specialty pharmacy industry. ... , Specialty drugs on the exchanges ... details of coinsurance levels by plan, by metal tier ...
(Date:7/22/2014)... Cumberland Pediatric Dentistry and Orthodontics stresses ... anxiety-free dental care for children, while maintaining the most ... care. , The orthodontic team is committed to ... adults and those with special needs. Whether a child ... unique care, such as cleft palate, Cumberland Pediatric Dentistry ...
Breaking Medicine News(10 mins):Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Latest Edition of Annual Book Provides Comprehensive Overview of the Specialty Pharmacy Arena 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 3
... new study published in the journal, Molecular Psychiatry suggested that ... susceptible to sleepwalking. Sleepwalking is a complex disorder and affects ... cent of adults. Though the condition is harmless, it may ... to others. Scientists examined a family of genes known as ...
... called C150T transition in people over 100 years old, a ... mutation was found in the mitochondrial DNA of white blood ... centenarians. The researchers found that 17 per cent of the ... 3.4 per cent of 117 control subjects under the age// ...
... all newly-diagnosed lung cancer cases. Smoking inflicts serious damage to ... quit, as it takes time for the tissue to recover. ... in the form of loss of a gene that could ... Texas have now shown that a close chemical relative of ...
... of the National Academy of Science, recently published a study ... that a brain protein called WAVE-1 may play a key ... found throughout the brain and plays an important role in ... that were produced, without the WAVE-1// protein, by the researchers ...
... by Juliette van den Dolder at the University of Nijmegen ... bone fractures with the help of specially prepared titanium mesh ... into a bone fracture in a rat. They allowed bone ... bone growth being stimulated by the bone// marrow cells. They ...
... it is no term to be happy about, because this ... could affect those individuals whose work or lifestyle demands them ... for a long time without a break could cause blood ... the lungs with possible fatal consequences. This condition is identical ...
Cached Medicine News:Health News:Bones repair themselves with bone marrow cells 2
... Mumps IgG Enzyme- linked Immunosorbent Assay (ELISA) ... determination of IgG antibody to Mumps virus ... be used for the determination of immune ... be used to demonstrate seroconversion or a ...
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
With BareWire technology, the wire crosses the lesion first, independent of the filter and delivery catheter. All other actions, including filter placement and retrieval, balloon dilatations, and ste...
... Ultra Laboratory has been uniquely designed ... single facility to integrated networks spanning ... to management reporting and accounts receivable, ... precise laboratory management. All system modules ...
Medicine Products: